John Borshoff – Managing Director – Deep Yellow (ASX:DYL) is successfully progressing a dual-pillar growth strategy to establish a globally diversified, Tier-1 uranium company to produce 10+ Mlb pa.
Copyright 2024 – Finance News Network
Source: Finance News Network
10 Oct 2023 - Jon Price - Managing Director - Richmond Vanadium Technology (ASX:RVT) is an Australian minerals development company which is advancing the Richmond – Julia Creek Vanadium Project in Queensland through a Bankable Feasibility Study.
Read More03 Dec 2020 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the market's record November month, expectations for 2021 and portfolio structuring.
Read More09 Sep 2020 - BrainChip Holdings Limited (ASX:BRN) President & CEO Louis DiNardo provides an update on collaboration and partnerships for the company's AI chip, Akida.
Read More25 Feb 2020 - Noxopharm Limited (ASX:NOX) Chief Medical Officer, Dr Gisela Mautner, talks about results from the company's LuPIN trial in prostate cancer, evaluating its lead product candidate, Veyonda, in combination with 177Lu-PSMA-617, a radiopharmaceutical therapy, in 56 patients with late-stage prostate cancer.
Read More17 Nov 2023 - Shaw and Partners Chief Investment Office Martin Crabb discusses when to get more bullish on equities.
Read More12 Aug 2020 - Galan Lithium Limited (ASX:GLN) Managing Director, Juan Pablo Vargas de la Vega talks about the company's lithium brine projects located within the South American Lithium Triangle in Argentina strategy and near-term targets.
Read More12 Aug 2024 - Jindalee Lithium Limited (ASX:JLL) CEO Ian Rodger provides an overview of the company, discussing the McDermitt project, progress on the PFS and grant funding.
Read More23 Apr 2021 - Capral Limited (ASX:CAA) Managing Director Tony Dragicevich talks about the company's strong FY20 results despite COVID, its product mix, operating environment and outlook.
Read More20 Aug 2021 - TALi Digital Limited (ASX:TD1) Managing Director Glenn Smith introduces the company’s software for the assessment and treatment of childhood attention difficulties and discusses the company's recent agreement with US company Akili.
Read More31 Mar 2021 - Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q) CEO and Managing Director James Graham talks about progress with the company's lead anti-infective candidate Recce 327, its expanding portfolio of synthetic anti-infectives targeting viral pathogens and a broad range of bacteria, clinical trial results and priorities for 2021.
Read More
